Physician profile
Patrick Soto
NPI 1821145509
$2,554.66
in general payments reported to CMS, 2019-2025
11 companies · $517 in 2025
The $517 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $137 · 2021: $362 · 2022: $527 · 2023: $77.26 · 2024: $321 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $665.55 | 2021-2025 | Intellis Adaptivestim |
| Nevro Corp. | $499.10 | 2019-2024 | Senza |
| Nalu Medical, INC. | $434.13 | 2022-2024 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $410.24 | 2019-2020 | |
| Boston Scientific Corporation | $265.35 | 2020-2021 | |
| Saluda Medical Americas, INC. | $163.89 | 2025 | Evoke |
| Amgen INC. | $36.15 | 2019 | |
| Globus Medical, INC. | $33.92 | 2025 | Senza |
| Allergan, INC. | $17.05 | 2019 | |
| Abbott Laboratories | $16.87 | 2019 | |
| Bioventus LLC | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.